Advertisement
Skip to Content

Advaxis Inc ADXS Stock Quote

PINX: ADXS

Last close prices updated as of Feb 06, 2023, 1:26 PM EST | USD
  • Last Close 1.975
  • Sector Healthcare
  • Industry Biotechnology
  • Investment Style Small Growth
  • Day Range 1.90  –  2.10
  • Year Range 1.00  –  11.52
  • Market Cap 3.5865 Mil
  • Volume / Avg 6,224.0 /  5,157.7
  • Price / Sales 14.38
  • Price / Book 0.13
  • Forward Div Yield
  • Trailing Div Yield

Morningstar‘s Stock Analysis ADXS

Valuation
Currency in
Is it the right time to buy or sell?
Is it the right time to buy or sell?

Economic Moat

INVESTOR

About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Unlock Our Full Analysis With Morningstar Investor

Key Statistics ADXS

Company Profile ADXS

Business Description

Advaxis Inc is a clinical-stage biotechnology company operating in the United States. It focuses on the discovery, development, and commercialization of proprietary Lm (Listeria monocytogenes)-LLO (Listeriolysin O) cancer immunotherapies. These immunotherapies are based on a platform technology that utilizes live attenuated Listeria monocytogenes (Lm) bioengineered to secrete antigen/adjuvant fusion proteins. The company's immunotherapy products based on Lm-LLO immunotherapy are Axalimogene filolisbac (AXAL) which targets Human Papilloma Virus (HPV) - associated cancers and ADXS-PSA which targets Prostate-Specific Antigen (PSA) associated with prostate cancer.

Contact
9 Deer Park Drive, Suite K-1
Monmouth Junction, NJ, 8540
Industry Biotechnology
Employees 15

FAQs for Advaxis Inc Stock

No. ADXS does not currently have a forward dividend yield.
Dividend yield allows investors, particularly those interested in dividend-paying stocks, to compare the relationship between a stock’s price and how it rewards stockholders through dividends. The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.

Learn more about dividend yield.

ADXS’s market cap is 3.59 Mil.
Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares. It’s often used to measure a company’s size. In the Morningstar Style Box, large-cap names account for the largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies.

Learn more about market capitalization.

ADXS’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.

Compare ADXS’s historical performance against its industry peers and the overall market.